Stock Research for ABT

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ABT Stock Chart & Research Data

The ABT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABT Due diligence Resources & Stock Charts

The ABT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABT Detailed Price Forecast - CNN Money CNN View ABT Detailed Summary - Google Finance
Yahoo View ABT Detailed Summary - Yahoo! Finance Zacks View ABT Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ABT Trends & Analysis - Trade-Ideas Barrons View ABT Major Holders - Barrons
NASDAQ View ABT Call Transcripts - NASDAQ Seeking View ABT Breaking News & Analysis - Seeking Alpha
Spotlight View ABT Annual Report - CompanySpotlight.com OTC Report View ABT OTC Short Report - OTCShortReport.com
TradeKing View ABT Fundamentals - TradeKing Charts View ABT SEC Filings - Bar Chart
WSJ View Historical Prices for ABT - The WSJ Morningstar View Performance/Total Return for ABT - Morningstar
MarketWatch View the Analyst Estimates for ABT - MarketWatch CNBC View the Earnings History for ABT - CNBC
StockMarketWatch View the ABT Earnings - StockMarketWatch MacroAxis View ABT Buy or Sell Recommendations - MacroAxis
Bullish View the ABT Bullish Patterns - American Bulls Short Pains View ABT Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ABT Stock Mentions - StockTwits PennyStocks View ABT Stock Mentions - PennyStockTweets
Twitter View ABT Stock Mentions - Twitter Invest Hub View ABT Investment Forum News - Investor Hub
Yahoo View ABT Stock Mentions - Yahoo! Message Board Seeking Alpha View ABT Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for ABT - SECform4.com Insider Cow View Insider Transactions for ABT - Insider Cow
CNBC View ABT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABT - OTC Markets
Yahoo View Insider Transactions for ABT - Yahoo! Finance NASDAQ View Institutional Holdings for ABT - NASDAQ


Stock Charts

FinViz View ABT Stock Insight & Charts - FinViz.com StockCharts View ABT Investment Charts - StockCharts.com
BarChart View ABT Stock Overview & Charts - BarChart Trading View View ABT User Generated Charts - Trading View


Latest Financial News for ABT

Zacks Industry Outlook Highlights: Boston Scientific, Stryker, Medtronic, Abbott and Varian Medical
Posted on Monday June 18, 2018

Zacks Industry Outlook Highlights: Boston Scientific, Stryker, Medtronic, Abbott and Varian Medical


How Much Upside Do Analysts See for Stryker?
Posted on Friday June 15, 2018

In this series, we’ll analyze what analysts think about the company, how its product lines have performed, and how its first-quarter financials look. Of the 27 analysts covering Stryker in June, 18 analysts have given the stock a “buy” or higher rating, while nine analysts have given it a “hold” rating. The mean rating for the stock is 2.0 with a target price of $181.36, implying upside potential of 7.5% over the stock’s closing price of $168.75 on June 14.


Should You Be Concerned With Abbott Laboratories’s (NYSE:ABT) -73.52% Earnings Drop?
Posted on Thursday June 14, 2018

When Abbott Laboratories (NYSE:ABT) announced its most recent earnings (31 March 2018), I did two things: looked at its past earnings track record, then look at what is happening inRead More...


Allergan appoints former Abbott executive to its board
Posted on Thursday June 14, 2018

Allergan, whose director Patrick O'Sullivan will retire from the board in July, said its board will continue to have 12 members of which 10 are independent, following the changes. Freyman, who retired from Abbott in 2017, most recently served as executive vice president, finance and administration for the company since June 2015.


Enter a stock symbol to view the stock details.